The Vasculitis Clinical Research Consortium (VCRC) is an integrated group of academic medical centers, patient support organizations, and clinical research resources dedicated to conducting clinical research in different forms of vasculitis. It is our goal to improve the care of patients with vasculitis.
The Vasculitis Clinical Research Consortium (VCRC) is a part of NIH Rare Diseases Clinical Research Network (RDCRN). Funding and/or programmatic support for this project has been provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the NIH Office of Rare Diseases Research (ORDR).
Principal Investigator of the Vasculitis Clinical Research Consortium, University of Pennsylvania Perelman School of Medicine
Dr. Merkel, a rheumatologist, is the Principal Investigator of the Vasculitis Clinical Research Consortium. He is also a Professor of Medicine and Epidemiology and Chief of the Division of Rheumatology at the University of Pennsylvania Perelman School of Medicine.
He received his medical degree from Yale University School of Medicine and performed his residency at the Hospital of the University of Pennsylvania. He earned his Master's of Public Health at Harvard School of Public Health, and later served as a clinical and research fellow in the Division of Rheumatology at Massachusetts General Hospital. Dr. Merkel is the PI or Co-PI on multiple NIH research grants that focus on clinical and translation investigation in vasculitis.
Principal Investigator of the Rare Diseases Clinical Research Network (RDCRN) Data Management and Coordinating Center (DMCC), University of South Florida
Dr. Krischer, an epidemiologist, is the Principal Investigator of the RDCRN Data and Management and Coordinating Center, Distinguished Professor of Pediatrics, Chief of the Division of Informatics and Biostatistics, and Director of the Pediatric Epidemiology Center at the University of South Florida. He is a collaborator with Dr. Peter Merkel in the conduct of vasculitis trials to investigate the natural history and explore innovative new treatments in multinational clinical research studies.
The Vasculitis Foundation is pleased to endorse The Assessment of Prednisone in Remission (TAPIR) Trial and encourages patients with granulomatosis with polyangiitis (GPA/Wegener's) to participate. Read More >
Ed Becker, Polyarteritis Nodosa Support Network
Mary Seubert, Polyarteritis Nodosa Support Network
*other conditions may apply. Learn more